Co-Diagnostics Revenue 2017-2024 | CODX
Co-Diagnostics revenue from 2017 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Co-Diagnostics Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $4 |
| 2023 | $7 |
| 2022 | $34 |
| 2021 | $98 |
| 2020 | $75 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| Co-Diagnostics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-12-31 | $0 |
| 2024-09-30 | $1 |
| 2024-06-30 | $3 |
| 2024-03-31 | $0 |
| 2023-12-31 | $4 |
| 2023-09-30 | $2 |
| 2023-06-30 | $0 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $5 |
| 2022-06-30 | $5 |
| 2022-03-31 | $23 |
| 2021-12-31 | $20 |
| 2021-09-30 | $30 |
| 2021-06-30 | $27 |
| 2021-03-31 | $20 |
| 2020-12-31 | $27 |
| 2020-09-30 | $22 |
| 2020-06-30 | $24 |
| 2020-03-31 | $2 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.012B | $0.004B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||